Assessment of Quadriceps Femoris Muscle Function in Patients After Arthroscopic Knee Surgery in Outpatient Rehabilitation

NCT ID: NCT06870825

Last Updated: 2025-03-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-01

Study Completion Date

2027-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn if a high intensity magnetic field is an effective way to treat quadriceps muscle atrophy after knee arthroscopic surgery in adult patients. The main questions it aims to answer are:

Is high intensity magnetic field muscle stimulation is an effective way to treat quadriceps muscle atrophy Is high intensity magnetic field muscle stimulation is more effective and more tolerable option for quadriceps muscle stimulation than transcutaneous muscle electrical stimulation Researchers will compare high intensity magnetic field muscle stimulation to transcutaneous muscle electrical stimulation and control group, to see if high intensity magnetic field muscle stimulation works to treat quadriceps muscle atrophy.

Participants will:

receive high intensity magnetic field or transcutaneous muscle electrical stimulation 1 time/day for 14 days, Visit the rehabilitation department for testing before/after and 1 month after rehabilitation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to evaluate the effectiveness of quadriceps muscle stimulation methods: transcutaneous neuromuscular electrostimulation (standard methodology) and high-intensity magnetic field (innovative methodology) stimulation in the rehabilitation of patients after arthroscopic knee surgery, and the impact of the applied methods on the quality of life.

Objectives:

1. To evaluate and check the quadriceps muscle volume, strength, knee joint motion amplitude, pain intensity before and after outpatient rehabilitation and to identify factors that may influence their occurrence.
2. To evaluate and compare the effectiveness of transcutaneous neuromuscular electrical stimulation and high-intensity magnetic field stimulation on changes in quadriceps muscle volume and strength in patients undergoing outpatient rehabilitation after knee joint arthroscopic surgeries.
3. To evaluate the impact of quadriceps muscle size and strength reduction on movement function and quality of life during outpatient rehabilitation, to evaluate changes in condition after outpatient rehabilitation and the previous 1 month, to compare the results obtained.
4. To establish and compare the tolerance of different muscle stimulation methods used and possible adverse reactions after arthroscopic knee joint surgeries.

Subject of the study:

Patients undergoing outpatient rehabilitation, according to the profile of musculoskeletal injuries, 14 days.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Meniscus Injury Meniscus Tear Arthroscopic Knee Surgeries ACL Injuries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High-intensity magnetic field muscle stimulation group

Group will receive High-intensity magnetic field muscle stimulation group to treat quadriceps muscle atrophy

Group Type EXPERIMENTAL

High-intensity Magnetic Field Muscle Stimulation

Intervention Type DEVICE

1. The procedure is performed for 20 min., 1k/d, 5k/week, a total of 14 times (rehabilitation duration 14 days).
2. Parameters: applied parameters according to the manufacturer's specified program for muscle stimulation: "muscle strengthening" program
3. Stimulation site: quadriceps femoris muscle, applied above the motor point approximately 60% of the distance from the upper medial border of the patella to the anterior upper wing of the iliac bone.
4. device: BLT Super Inductive System

* Along with muscle stimulation techniques, all subjects will undergo a standardized outpatient rehabilitation plan.

Transcutaneous neuromuscular electrical stimulation group

Group will receive a Transcutaneous neuromuscular electrical stimulation to treat quadriceps muscle atrophy

Group Type ACTIVE_COMPARATOR

Transcutaneous Neuromuscular Electrical Stimulation

Intervention Type DEVICE

1. the procedure is performed for 20 min., 1k/d, 5k/week, a total of 14 times (rehab. duration 14 days).
2. Parameters: applied parameters according to the manufacturer's specified program for muscle stimulation (EMS, P3)
3. Stimulation site: quadriceps femoris muscle, applied above the motor point.
4. device: ITO ES-5200

* Along with muscle stimulation techniques, all subjects will undergo a standardized outpatient rehabilitation plan.

Control group

A Control group, that will receive a standard outpatient rehabilitation plan, without additional quadriceps muscle stimulation methodology.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High-intensity Magnetic Field Muscle Stimulation

1. The procedure is performed for 20 min., 1k/d, 5k/week, a total of 14 times (rehabilitation duration 14 days).
2. Parameters: applied parameters according to the manufacturer's specified program for muscle stimulation: "muscle strengthening" program
3. Stimulation site: quadriceps femoris muscle, applied above the motor point approximately 60% of the distance from the upper medial border of the patella to the anterior upper wing of the iliac bone.
4. device: BLT Super Inductive System

* Along with muscle stimulation techniques, all subjects will undergo a standardized outpatient rehabilitation plan.

Intervention Type DEVICE

Transcutaneous Neuromuscular Electrical Stimulation

1. the procedure is performed for 20 min., 1k/d, 5k/week, a total of 14 times (rehab. duration 14 days).
2. Parameters: applied parameters according to the manufacturer's specified program for muscle stimulation (EMS, P3)
3. Stimulation site: quadriceps femoris muscle, applied above the motor point.
4. device: ITO ES-5200

* Along with muscle stimulation techniques, all subjects will undergo a standardized outpatient rehabilitation plan.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years and older (working age).
* Arthroscopic knee joint surgery performed
* The dr. orthopedic traumatologist allowed the operated limb to be activated - and rehabilitation to begin
* The period between the operation and the start of rehabilitation is not shorter than 4 weeks and not longer than 2 months.
* Impaired self-service or movement function: Barthel index 80 points or more (according to the order of the Ministry of Health of the Republic of Lithuania) Subjects agreeing to participate in the study

Exclusion Criteria

* Contraindications to electrostimulation or high-intensity magnetic therapy:

1. Epilepsy
2. Implanted electrical devices
3. Acute rhythm disorders
4. Oncological diseases (near the stimulation site, active treatment)
5. Sensory disorders
6. Skin lesions (near the stimulation site)
7. Pregnancy.
* Cannot perform the functional tests presented in the study.
* Subjects who cannot be treated with a standardized outpatient rehabilitation plan due to other contraindications (e.g. IC, DVT)
* Subjects who refuse to participate in the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lithuanian University of Health Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gintare Repeckaite

assistant teacher, phd student.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lithuanian University of Health Sciences

Kaunas, , Lithuania

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Lithuania

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P2-BE-2-60/2024

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Muscle Recovery After Total Knee Arthroplasty
NCT06096792 ACTIVE_NOT_RECRUITING